The University of Utah College of Pharmacy announced that it will be awarded $24.5m of federal money to carry on research on treatments for drug-resistant epilepsy.
Subscribe to our email newsletter
The university is set to enter a five-year contract with the Anticonvulsant Drug Development Program within the National Institutes of Health, therepublic.com reported, citing The Associated Press.
Utah College of Pharmacy is said to have been a part of anti-epilepsy drugs development over the last 30 years.
Epilepsy is a neurological disorder where the patients experience repeated seizures.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.